共 196 条
[1]
Shafiee G(2017)Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II) BMJ Open 7 2137-2153
[2]
Ostovar A(2022)Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis Osteoporos Int 33 1-20
[3]
Heshmat R(2021)The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis J Orthop Surg Res 16 185-202
[4]
Darabi H(2014)Medication-induced osteoporosis: screening and treatment strategies Therapeutic Adv Musculoskelet Disease 6 309-314
[5]
Sharifi F(2022)Treatment of diabetes and osteoporosis—a reciprocal risk Biomedicines 10 1470-1483
[6]
Raeisi A(2019)Prevalence and risk factors of Sarcopenia in patients with Diabetes: a meta-analysis Sarcopenia Joint Bone Spine 86 1-8
[7]
Mehrdad N(2022)Oral Drugs related with muscle wasting and sarcopenia. A review J Clin Endocrinol Metabolism 107 609-618
[8]
Xiao PL(2017)Osteosarcopenia: epidemiology, diagnosis, and treatment—facts and numbers Pharmacology 99 364-370
[9]
Cui AY(2020)Prevalence of osteosarcopenia and its association with cardiovascular risk factors in Iranian older people: Bushehr Elderly Health (BEH) Program J Cachexia Sarcopenia Muscle 11 853-858
[10]
Hsu CJ(2020)Osteosarcopenia predicts falls, fractures, and mortality in Chilean community-dwelling older adults Calcif Tissue Int 106 1-15